Items 91 to 100 of 465 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3-Hydroxy Simvastatin Acid, Sodium Salt | 1316302-95-0 | sc-216638 sc-216638A | 2.5 mg 10 mg | $448.00 $1290.00 | ||
3”-Hydroxy Simvastatin Acid, Sodium Salt functions as a chiral reagent characterized by its ability to engage in specific molecular interactions that favor enantioselective transformations. Its unique hydroxyl group enhances solubility and reactivity, allowing for effective coordination with various substrates. The compound's ionic nature promotes strong electrostatic interactions, facilitating selective pathways in catalytic processes and optimizing reaction kinetics for improved yields. | ||||||
Griseofulvin-13C,d3 | 126-07-8 (unlabeled) | sc-280762 | 1 mg | $268.00 | ||
Griseofulvin-13C,d3 serves as a chiral reagent distinguished by its unique structural features that enable selective molecular interactions. Its isotopic labeling enhances the tracking of reaction pathways, providing insights into mechanistic details. The compound's ability to form stable complexes with chiral catalysts influences stereochemical outcomes, while its distinct conformational flexibility allows for tailored reactivity in asymmetric synthesis, optimizing enantioselectivity. | ||||||
Xanthophyll | 127-40-2 | sc-220391 sc-220391A | 25 mg 100 mg | $250.00 $900.00 | 2 | |
Xanthophyll acts as a chiral reagent characterized by its intricate stereochemical framework, which facilitates specific interactions with substrates. Its unique arrangement of functional groups promotes selective binding, influencing reaction kinetics and enhancing enantioselectivity. The compound's ability to engage in hydrogen bonding and π-π stacking interactions allows for the stabilization of transition states, thereby guiding the formation of desired chiral products in asymmetric reactions. | ||||||
Methicillin Sodium Salt | 132-92-3 | sc-394118 | 50 mg | $94.00 | ||
Methicillin Sodium Salt serves as a chiral reagent, distinguished by its unique structural features that enable selective interactions with various substrates. Its specific arrangement of functional groups fosters unique steric and electronic environments, promoting enantioselective pathways. The compound's capacity for forming non-covalent interactions, such as hydrogen bonds and ionic interactions, enhances its effectiveness in stabilizing transition states, ultimately guiding the synthesis of chiral compounds. | ||||||
Dextrorphan, Tartrate Salt | 143-98-6 | sc-391819 | 5 mg | $198.00 | 1 | |
Dextrorphan, Tartrate Salt functions as a chiral reagent, characterized by its ability to facilitate asymmetric synthesis through its specific stereochemical configuration. The compound exhibits unique solvation properties, influencing reaction kinetics and enhancing selectivity in chiral transformations. Its capacity to engage in stereospecific interactions allows for the stabilization of chiral intermediates, promoting efficient pathways in the formation of enantiomerically enriched products. | ||||||
Galanthamine | 357-70-0 | sc-218556 | 10 mg | $320.00 | ||
Galanthamine serves as a chiral reagent, notable for its ability to form stable complexes with various substrates, enhancing enantioselectivity in reactions. Its unique molecular structure allows for specific hydrogen bonding and π-π stacking interactions, which can influence reaction pathways. The compound's steric hindrance plays a crucial role in directing the orientation of reactants, thereby optimizing the formation of desired chiral products with improved yields. | ||||||
(4bS)-trans-8,8-Trimethyl-4b,5,6,7,8,8a,9,10-octahydro-1-isopropylphenanthren-2-ol | 511-15-9 | sc-226866 sc-226866A sc-226866B sc-226866C | 100 mg 500 mg 1 g 2 g | $183.00 $714.00 $1321.00 $2081.00 | 1 | |
(4bS)-trans-8,8-Trimethyl-4b,5,6,7,8,8a,9,10-octahydro-1-isopropylphenanthren-2-ol acts as a chiral reagent characterized by its distinctive three-dimensional conformation, which facilitates selective interactions with substrates. Its rigid framework promotes unique steric effects, influencing reaction kinetics and enhancing enantioselectivity. The compound's ability to engage in specific non-covalent interactions, such as van der Waals forces, further optimizes chiral induction in synthetic pathways. | ||||||
(S)-(+)-1-Bromo-2-methylbutane | 534-00-9 | sc-258115 | 1 g | $61.00 | ||
(S)-(+)-1-Bromo-2-methylbutane serves as a chiral reagent, notable for its asymmetric carbon center that imparts chirality to reactions. Its unique steric configuration allows for selective binding with nucleophiles, enhancing enantioselectivity in various synthetic processes. The compound's reactivity as an alkyl halide facilitates nucleophilic substitution reactions, where the spatial arrangement of substituents plays a critical role in determining product outcomes and reaction rates. | ||||||
Tabersonine | 4429-63-4 | sc-391702 sc-391702A sc-391702B | 10 mg 25 mg 100 mg | $320.00 $471.00 $1540.00 | ||
Tabersonine is a chiral reagent characterized by its distinctive molecular framework, which promotes specific stereochemical interactions during reactions. Its unique conformation enables selective coordination with electrophiles, leading to enhanced enantioselectivity. The compound's reactivity profile allows it to participate in diverse synthetic pathways, where its spatial arrangement significantly influences reaction kinetics and product distribution, making it a valuable tool in asymmetric synthesis. | ||||||
Norgestrel | 6533-00-2 | sc-205415 sc-205415A | 100 mg 500 mg | $39.00 $174.00 | ||
Norgestrel is a chiral reagent notable for its ability to facilitate asymmetric transformations through its unique stereogenic centers. The compound exhibits selective binding properties, allowing it to interact preferentially with certain substrates, which enhances enantioselectivity in reactions. Its structural features contribute to distinct reaction pathways, influencing both the rate and outcome of chemical processes, thereby serving as an effective agent in chiral synthesis. | ||||||